Trials / Completed
CompletedNCT00621868
A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus
ASP1941 Phase II Clinical Study - A Double-blind, Placebo-controlled, Parallel-group, Dose-response Study in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 361 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of ASP1941 in male and female patients with type 2 diabetes mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ipragliflozin | Oral |
| DRUG | Placebo | Oral |
Timeline
- Start date
- 2008-03-26
- Primary completion
- 2009-03-14
- Completion
- 2009-03-14
- First posted
- 2008-02-22
- Last updated
- 2024-11-12
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00621868. Inclusion in this directory is not an endorsement.